Allergy and Asthma Medical Group and Research Center, San Diego, California, USA.
Ann Allergy Asthma Immunol. 2011 Feb;106(2 Suppl):S12-6. doi: 10.1016/j.anai.2010.10.014.
To describe the economic burden of allergic rhinitis treatment and current guidelines for treatment.
Review articles and original research were retrieved from MEDLINE, OVID, PubMed (1950-November 2009), personal files of articles, and bibliographies of located articles that addressed the topic of interest.
Articles were selected for their relevance to the burden of allergic rhinitis and current guidelines for treatment. Publications included reviews, treatment guidelines, and clinical studies.
Despite the common symptoms of allergic rhinitis, its impact on patient quality of life, and the huge cost to society and individuals of treatment, including pharmacotherapy, many patients do not adhere to their medication regimens because the medications do not adequately address their symptoms or are otherwise problematic for them to use.
The economic impact of allergic rhinitis is substantial; the total direct medical cost of allergic rhinitis is approximately $3.4 billion, with almost half of this cost attributable to prescription medications. Multiple treatment options are available, and these were reviewed to provide an update on effectiveness and adverse effects that may affect patient adherence.
描述变应性鼻炎治疗的经济负担和目前的治疗指南。
从 MEDLINE、OVID、PubMed（1950 年-2009 年 11 月）、文章的个人档案和找到的相关文章的参考文献中检索到了评论文章和原始研究，这些文章都涉及到感兴趣的主题。
选择与变应性鼻炎的负担和目前的治疗指南相关的文章。出版物包括综述、治疗指南和临床研究。
尽管变应性鼻炎有共同的症状，对患者生活质量有影响，并且治疗包括药物治疗在内，给社会和个人带来了巨大的成本，但许多患者不遵守他们的药物治疗方案，因为药物不能充分缓解他们的症状，或者使用起来对他们有问题。
变应性鼻炎的经济影响是巨大的；变应性鼻炎的直接医疗总费用约为 34 亿美元，其中近一半的费用归因于处方药物。有多种治疗选择，对这些治疗方法进行了回顾，以提供有关有效性和不良反应的最新信息，这些可能会影响患者的依从性。
